...
首页> 外文期刊>Arthroscopy: the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association >Patient-Centered Outcomes and Revision Rate in Patients Undergoing ACL Reconstruction Using Bone-Patellar Tendon-Bone Autograft Compared With Bone-Patellar Tendon-Bone Allograft: A Matched Case-Control Study
【24h】

Patient-Centered Outcomes and Revision Rate in Patients Undergoing ACL Reconstruction Using Bone-Patellar Tendon-Bone Autograft Compared With Bone-Patellar Tendon-Bone Allograft: A Matched Case-Control Study

机译:以病人为中心的结果和修正率接受ACL重建的患者使用自体骨-髌腱-骨移植相比异体骨-髌腱-骨:匹配病例对照研究

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: To determine whether outcomes after ACL reconstruction with bone-patellar tendon-bone (BPTB) autograft are similar to those of BPTB allograft, while controlling for graft, surgical technique, and surgeon. Methods: This study was approved by the institutional review board at The Vail ValleyMedical Center in Vail, Colorado. Patients 18 to 70 years oldwho underwent primary ACL reconstruction were included. Patients in each group were matched by age and gender. Patient demographic data, surgical data, and subjective data were collected prospectively. Subjective questionnaires were administered at a minimum of 2 years after ACL reconstruction. Results: This study included 192 knees (191 patients; 143 male, 48 female; mean age, 33 years; range, 18 to 57 years), with 96 knees in each group. No autografts required ACL revision. The revision rate for allograft group was 14% (n = 11; mean age, 23 years; range, 18 to 40 years). Of 11 revisions, 9 (82%) were 25 years (P < .001). Follow-up was available for 87% of patients (n = 156/180). Mean follow-up time in the allograft group was 4.7 years (range, 2.0 to 9.8 years), and in the autograft group, 8.6 years (range, 2.0 to 16.2 years; P < .001). There was no significant difference between allografts and autografts for mean Lysholm (85.6 v 83.4; P = .43), mean Tegner (6.0 v 5.4; P = .09), or mean patient satisfaction (9.0 v 8.8; P = .57). Lysholm score correlated to Tegner (rho = 0.404; P <= .001) and patient satisfaction with outcome (rho = 0.443; P <= .001). Tegner was correlated with age at surgery (rho = -0.274; P < .001). Conclusions: There was no significant difference in patient-centered outcomes based on graft type; however, the allograft group required more revisions. Patient satisfaction was high for both groups. ACL reconstruction using BPTB autograft or allograft produces similar outcomes; however, revision rates were higher for allografts.
机译:目的:确定ACL后的结果重建与骨-髌腱-骨(BPTB)自体BPTB类似同种异体移植物,虽然控制了移植,手术技术,外科医生。机构审查委员会的批准科罗拉多州维尔维尔ValleyMedical中心。病人18到70年oldwho进行初选ACL重建被包括在内。每组被年龄和性别匹配。病人人口数据,手术数据,前瞻性地收集了主观数据。主观问卷管理的ACL重建后2年以上。结果:本研究包括192膝盖(191病人;年;每组。修订的同种异体移植物组为14% (n= 11;11修订、9(82%) 25年(P <措施)。病人(n = 156/180)。同种异体移植物组4.7年(范围2.09.8年),自体移植物组8.6年(范围2.0 - 16.2年;同种异体之间没有显著差异意味着Lysholm缺损(85.6 v 83.4;点),意味着Tegner (6.0 v 5.4;病人满意度(9.0 v 8.8;Lysholm分数相关Tegner(ρ= 0.404;P < =措施)和患者满意的结果(ρ= 0.443;随着年龄的增长在手术(ρ= -0.274;结论:没有显著差异以病人为中心的结果根据移植类型;然而,同种异体移植物组需要更多修订。组。或同种异体移植物产生相似的结果;修订为同种异体率更高。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号